Company intelligence / Profile preview

FemTherapeutics

Montreal, Quebec, Canadafemtherapeutics.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

FemTherapeutics has developed a custom-fitted, disposable vaginal pessary for the management of pelvic organ prolapse. Their solution leverages artificial intelligence and patient-specific data to design and manufacture personalized devices using biocompatible materials and 3D printing. A successful feasibility study was completed in early 2023 with several patients fitted with the custom pessary. The company plans to launch pivotal clinical studies in North America and aims for commercial availability in the US and Canada by 2026.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Mayo Clinic Platform_Accelerate program (data/model training partnership)

Beyond the preview

Go deeper on FemTherapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FemTherapeutics.

Explore the full profile